Pharmaceutically active secondary metabolites of marine actinobacteria

Microbiological Research

Volumn 169, Issue 4, 2014, Pages 262-278

  Manivasagan, Panchanathan ^a   Venkatesan, Jayachandran ^a   Sivakumar, Kannan ^b   Kim, Se Kwon ^a  

^a Pukyong National University   (South Korea)

^b ANNAMALAI UNIVERSITY   (India)

Author keywords

Antibiotics; Bioactive compounds; Marine actinobacteria; Secondary metabolites

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL PRODUCT;

ACTINOBACTERIA; AQUATIC SPECIES; BIOACTIVE COMPOUNDS; CHEMISTRY; DRUG DEVELOPMENT; ISOLATION AND PURIFICATION; MARINE ACTINOBACTERIA; MEDICAL RESEARCH; REVIEW; SECONDARY METABOLISM; SECONDARY METABOLITES;

ANTIBIOTICS; BIOACTIVE COMPOUNDS; MARINE ACTINOBACTERIA; SECONDARY METABOLITES;

ACTINOBACTERIA; AQUATIC ORGANISMS; BIOLOGICAL PRODUCTS; BIOMEDICAL RESEARCH; DRUG DISCOVERY; SECONDARY METABOLISM;

EID: 84894298829     PISSN: 09445013     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micres.2013.07.014     Document Type: Review

References (153)

1. Abdel-Mageed W.M., Milne B.F., Wagner M., Schumacher M., Sandor P., Pathom-aree W., et al. Dermacozines, a new phenazine family from deep-sea dermacocci isolated from a Mariana Trench sediment. Org Biomol Chem 2010, 8(10):2352-2362.
2. Abdelmohsen U.R., Pimentel-Elardo S.M., Hanora A., Radwan M., Abou-El-Ela S.H., Ahmed S., et al. Isolation, phylogenetic analysis and anti-infective activity screening of marine sponge-associated actinomycetes. Mar Drugs 2010, 8(3):399-412.
3. Aggarwal B.B., Sethi G., Nair A., Ichikawa H. Nuclear factor-B: a Holy Grail in cancer prevention and therapy. Curr Signal Transduction Therapy 2006, 1(1):25-52.
4. Anderson A.S., Wellington E. The taxonomy of Streptomyces and related genera. Int J Syst Evol Microbiol 2001, 51(3):797-814.
5. Antony-Babu S., Stach J.E., Goodfellow M. Genetic and phenotypic evidence for Streptomyces griseus ecovars isolated from a beach and dune sand system. Antonie Van Leeuwenhoek 2008, 94(1):63-74.
6. Arumugam M., Mitra A., Jaisankar P., Dasgupta S., Sen T., Gachhui R., et al. Isolation of an unusual metabolite 2-allyloxyphenol from a marine actinobacterium, its biological activities and applications. Appl Microbiol Biotechnol 2010, 86(1):109-117.
7. Asolkar R.N., Maskey R.P., Helmke E., Laatsch H. Chalcomycin B, a new macrolide antibiotic from the marine isolate Streptomyces sp. B7064. J Antibiot 2002, 55(10):893-898.
8. Asolkar R.N., Jensen P.R., Kauffman C.A., Fenical W. Daryamides AC, weakly cytotoxic polyketides from a marine-derived actinomycete of the genus Streptomyces strain CNQ-085. J Nat Prod 2006, 69(12):1756-1759.
9. Asolkar R.N., Schroeder D., Heckmann R., Lang S., Wagner-Doebler I., Laatsch H. Helquinoline, a new tetrahydroquinoline antibiotic from Janibacter limosus Hel 1. J Antibiot (Tokyo) 2004, 57:17-23.
10. Asolkar R.N., Freel K.C., Jensen P.R., Fenical W., Kondratyuk T.P., Park E.-J., et al. Arenamides A-C, cytotoxic NFκB inhibitors from the marine Actinomycete Salinispora arenicola. J Nat Prod 2008, 72(3):396-402.
11. Atlas R.M., Bartha R. Microbial ecology: fundamentals and applications 1986, 174-217. Cummings Pub, New York, Benjamin. 4th ed.
12. Baltz R. Antibiotic discovery from actinomycetes: will a renaissance follow the decline and fall. SIM News 2005, 55(5):186-196.
13. Baltz R.H. Marcel Faber Roundtable: is our antibiotic pipeline unproductive because of starvation, constipation or lack of inspiration?. J Ind Microbiol Biotechnol 2006, 33(7):507-513.
14. Bentley S., Chater K., Cerdeno-Tarraga A.-M., Challis G., Thomson N., James K., et al. Complete genome sequence of the model actinomycete Streptomyces coelicolor A3 (2). Nature 2002, 417(6885):141-147.
15. Berdy J. Bioactive microbial metabolites. J Antibiot 2005, 58(1):1-26.
16. Bernan V., Greenstein M., Carter G. Mining marine microorganisms as a source of new antimicrobials and antifungals. Curr Med Chem - Anti-Infective Agents 2004, 3(3):181-195.
17. Bister B., Bischoff D., Stroebele M., Riedlinger J., Reicke A., Wolter F., et al. Abyssomicin C-a polycyclic antibiotic from a marine Verrucosispora strain as an inhibitor of the p-aminobenzoic acid/tetrahydrofolate biosynthesis pathway. Angew Chem Int Ed 2004, 43(19):2574-2576.
18. Blunt J.W., Copp B.R., Munro M.H., Northcote P.T., Prinsep M.R. Marine natural products. Nat Prod Rep 2006, 23:26-78.
19. Borrel M.N., Pereira E., Fiallo M., Garnier Suillerot A. Mobile ionophores are a novel class of P-glycoprotein inhibitors. Eur J Biochem 2005, 223(1):125-133.
20. Bruntner C., Binder T., Pathom-aree W., Goodfellow M., Bull A.T., Potterat O., et al. Frigocyclinone, a novel Angucyclinone antibiotic produced by a Streptomyces griseus strain from Antarctica. J Antibiot 2005, 58(5):346-349.
21. Burg R.W., Miller B.M., Baker E.E., Birnbaum J., Currie S.A., Hartman R., et al. Avermectins, new family of potent anthelmintic agents: producing organism and fermentation. Antimicrob Agents Chemother 1979, 15(3):361-367.
22. Carlson J.C., Li S., Burr D.A., Sherman D.H. Isolation and characterization of tirandamycins from a marine-derived Streptomyces sp. J Nat Prod 2009, 72(11):2076-2079.
23. Charan R.D., Schlingmann G., Janso J., Bernan V., Feng X., Carter G.T. Diazepinomicin, a new antimicrobial alkaloid from a marine Micromonospora sp. J Nat Prod 2004, 67(8):1431-1433.
24. Chauhan D., Catley L., Li G., Podar K., Hideshima T., Velankar M., et al. A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib. Cancer Cell 2005, 8(5):407-419.
25. Cho J.Y., Williams P.G., Kwon H.C., Jensen P.R., Fenical W. Lucentamycins AD, cytotoxic peptides from the marine-derived actinomycete Nocardiopsis lucentensis. J Nat Prod 2007, 70(8):1321-1328.
26. Cho J.Y., Kwon H.C., Williams P.G., Kauffman C.A., Jensen P.R., Fenical W. Actinofuranones A and B, polyketides from a marine-derived bacterium related to the genus Streptomyces (Actinomycetales). J Nat Prod 2006, 69(3):425-428.
27. Croft S.L., Coombs G.H. Leishmaniasis - current chemotherapy and recent advances in the search for novel drugs. Trends Parasitol 2003, 19(11):502-508.
28. Dasari V.R.R.K., Muthyala M.K.K., Nikku M.Y., Donthireddy S.R.R. Novel Pyridinium compound from marine actinomycete, Amycolatopsis alba var. nov., DVR D4 showing antimicrobial and cytotoxic activities in vitro. Microbiol Res 2012, 167:346-351.
29. Daszak P., Cunningham A.A., Hyatt A.D. Emerging infectious diseases of wildlife-threats to biodiversity and human health. Science 2000, 287(5452):443-449.
30. Dekkers J., Van Doornen L., Kemper H. The role of antioxidant vitamins and enzymes in the prevention of exercise-induced muscle damage. Sports Med (Auckland, NZ) 1996, 21(3):213-238.
31. Demain A.L., Sanchez S. Microbial drug discovery: 80 years of progress. J Antibiot 2009, 62(1):5-16.
32. Dharmaraj S. Marine Streptomyces as a novel source of bioactive substances. World J Microbiol Biotechnol 2010, 26(12):2123-2139.
33. Ekwenye U.N., Kazi E. Investigation of plasmid DNA and antibiotic resistance in some pathogenic organisms. Afr J Biotechnol 2007, 6(7):877-880.
34. El-Gendy M.M., Shaaban M., Shaaban K.A., El-Bondkly A.M., Laatsch H. Essramycin: a first triazolopyrimidine antibiotic isolated from Nature. J Antibiot 2008, 61(3):149-157.
35. Engelhardt K., Degnes K.F., Kemmler M., Bredholt H., Fjærvik E., Klinkenberg G., et al. Production of a new thiopeptide antibiotic, TP-1161, by a marine Nocardiopsis species. Appl Environ Microbiol 2010, 76(15):4969-4976.
36. Feling R.H., Buchanan G.O., Mincer T.J., Kauffman C.A., Jensen P.R., Fenical W. Salinosporamide A: a highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus Salinospora. Angew Chem Int Ed 2003, 42(3):355-357.
37. Fenical W., Jensen P.R. Developing a new resource for drug discovery: marine actinomycete bacteria. Nat Chem Biol 2006, 2(12):666-673.
38. Fenical W., Sethna K., Lloyd G. Marine microorganisms as a developing resource for drug discovery. Pharm News 2002, 9(6):489-494.
39. Fenical W., Jensen P.R., Palladino M.A., Lam K.S., Lloyd G.K., Potts B.C. Discovery and development of the anticancer agent salinosporamide A (NPI-0052). Bioorg Med Chem 2009, 17(6):2175-2180.
40. Fiedler H.-P., Bruntner C., Riedlinger J., Bull A.T., Knutsen G., Goodfellow M., et al. Proximicin A, B and C, novel aminofuran antibiotic and anticancer compounds isolated from marine strains of the actinomycete Verrucosispora. J Antibiot 2008, 61(3):158-163.
41. Folkman J. What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst 1990, 82(1):4-7.
42. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995, 1(1):27-30.
43. Gao X., Lu Y., Xing Y., Ma Y., Lu J., Bao W., et al. A novel anticancer and antifungus phenazine derivative from a marine actinomycete BM-17. Microbiol Res 2012, 167:616-622.
44. Gillet J.-P., Efferth T., Remacle J. Chemotherapy-induced resistance by ATP-binding cassette transporter genes. Biochim Biophys Acta (BBA) - Rev Cancer 2007, 1775(2):237-262.
45. Gorajana A., Kurada B.V., Peela S., Jangam P., Vinjamuri S., Poluri E., et al. 1-Hydroxy-1-norresistomycin, a new cytotoxic compound from a marine Actinomycete, Streptomyces chibaensis AUBN1/7. J Antibiot 2005, 58(8):526-529.
46. Gorajana A., Vinjamuri S., Kurada B.V., Peela S., Jangam P., Poluri E., et al. Resistoflavine, cytotoxic compound from a marine actinomycete, Streptomyces chibaensis AUBN 1/7. Microbiol Res 2007, 162(4):322-327.
47. Han S.K., Nedashkovskaya O.I., Mikhailov V.V., Kim S.B., Bae K.S. Salinibacterium amurskyense gen. nov., sp. nov., a novel genus of the family Microbacteriaceae from the marine environment. Int J Syst Evol Microbiol 2003, 53(6):2061-2066.
48. Han Y., Yang B., Zhang F., Miao X., Li Z. Characterization of antifungal chitinase from marine Streptomyces sp., DA11 associated with South China Sea sponge Craniella australiensis. Mar Biotechnol 2009, 11(1):132-140.
49. Hardt I.H., Jensen P.R., Fenical W. Neomarinone, and new cytotoxic marinone derivatives, produced by a marine filamentous bacterium (Actinomycetales). Tetrahedron Lett 2000, 41(13):2073-2076.
50. Hawas U.W., Shaaban M., Shaaban K.A., Speitling M., Maier A., Kelter G., et al. Mansouramycins A-D, cytotoxic isoquinolinequinones from a marine Streptomycete. J Nat Prod 2009, 72(12):2120-2124.
51. Hayakawa Y., Shirasaki S., Kawasaki T., Matsuo Y., Adachi K., Shizuri Y. Structures of new cytotoxic antibiotics, piericidins C7 and C8. J Antibiot 2007, 60(3):201-203.
52. Hayakawa Y., Shirasaki S., Shiba S., Kawasaki T., Matsuo Y., Adachi K., et al. Piericidins C7 and C8, new cytotoxic antibiotics produced by a marine Streptomyces sp. J Antibiot 2007, 60(3):196-200.
53. Helaly S.E., Pesic A., Fiedler H.P., Süssmuth R.D. Elaiomycins B and C: alkylhydrazide antibiotics from Streptomyces sp. BK 190. Org Lett 2011, 13(5):1052-1055.
54. Helmke E., Weyland H. Rhodococcus marinonascens sp. nov., an actinomycete from the sea. Int J Syst Bacteriol 1984, 34(2):127-138.
55. Hohmann C., Schneider K., Bruntner C., Irran E., Nicholson G., Bull A.T., et al. Caboxamycin, a new antibiotic of the benzoxazole family produced by the deep-sea strain Streptomyces sp NTK 937&ast. J Antibiot 2009, 62(2):99-104.
56. Hohmann C., Schneider K., Bruntner C., Brown R., Jones A.L., Goodfellow M., et al. Albidopyrone, a new α-pyrone-containing metabolite from marine-derived Streptomyces sp. NTK 227. J Antibiot 2009, 62(2):75-79.
57. Huang Y.F., Tian L., Fu H.W., Hua H.M., Pei Y.H. One new anthraquinone from marine Streptomyces sp. FX-58. Nat Prod Res 2006, 20(13):1207-1210.
58. Hughes C.C., Prieto-Davo A., Jensen P.R., Fenical W. The marinopyrroles, antibiotics of an unprecedented structure class from a marine Streptomyces sp. Org Lett 2008, 10(4):629-631.
59. Jensen P.R., Gontang E., Mafnas C., Mincer T.J., Fenical W. Culturable marine actinomycete diversity from tropical Pacific Ocean sediments. Environ Microbiol 2005, 7(7):1039-1048.
60. Jensen P.R., Williams P.G., Oh D.C., Zeigler L., Fenical W. Species-specific secondary metabolite production in marine actinomycetes of the genus Salinispora. Appl Environ Microbiol 2007, 73(4):1146-1152.
61. Jeong S.-Y., Shin H.J., Kim T.S., Lee H.-S., Park S.-K., Kim H.M. Streptokordin, a new cytotoxic compound of the methylpyridine class from a marine-derived Streptomyces sp. KORDI-3238. J Antibiot 2006, 59(4):234-240.
62. Jones K.E., Patel N.G., Levy M.A., Storeygard A., Balk D., Gittleman J.L., et al. Global trends in emerging infectious diseases. Nature 2008, 451(7181):990-993.
63. Jørgensen H., Degnes K.F., Dikiy A., Fjærvik E., Klinkenberg G., Zotchev S.B. Insights into the evolution of macrolactam biosynthesis through cloning and comparative analysis of the biosynthetic gene cluster for a novel macrocyclic lactam, ML-449. Appl Environ Microbiol 2010, 76(1):283-293.
64. Kaczmarski M., Wójcicki J., Samochowiec L., Dutkiewicz T., Sych Z. The influence of exogenous antioxidants and physical exercise on some parameters associated with production and removal of free radicals. Pharmazie 1999, 54:303-306.
65. Kalaitzis J.A., Hamano Y., Nilsen G., Moore B.S. Biosynthesis and structural revision of neomarinone. Org Lett 2003, 5(23):4449-4452.
66. Kanoh K., Matsuo Y., Adachi K., Imagawa H., Nishizawa M., Shizuri Y. Mechercharmycins A and B, cytotoxic substances from marine-derived Thermoactinomyces sp. YM3-251. J Antibiot 2005, 58(4):289-292.
67. Kock I., Maskey R.P., Biabani M.A.F., Helmke E., Laatsch H. 1-Hydroxy-1-norresistomycin and resistoflavin methyl ether: new antibiotics from marine-derived streptomycetes. J Antibiot 2005, 58(8):530-535.
68. Koehn F.E., Carter G.T. The evolving role of natural products in drug discovery. Nat Rev Drug Discovery 2005, 4(3):206-220.
69. Kumar S.S., Philip R., Achuthankutty C. Antiviral property of marine actinomycetes against white spot syndrome virus in penaeid shrimps. Curr Sci 2006, 91(6):807-811.
70. Kwon H.C., Kauffman C.A., Jensen P.R., Fenical W., Marinomycins A.D. antitumor-antibiotics of a new structure class from a marine actinomycete of the recently discovered genus "Marinispora". J Am Chem Soc 2006, 128(5):1622-1632.
71. Lam K.S. Discovery of novel metabolites from marine actinomycetes. Curr Opin Microbiol 2006, 9(3):245-251.
72. Lee J.-G., Yoo I.-D., Kim W.-G. Differential antiviral activity of benzastatin C and its dechlorinated derivative from Streptomyces nitrosporeus. Biol Pharm Bull 2007, 30(4):795-797.
73. Li F., Maskey R.P., Qin S., Sattler I., Fiebig H.H., Maier A., et al. Chinikomycins A and B: Isolation, structure elucidation, and biological activity of novel antibiotics from a marine Streptomyces sp. isolate M045. J Nat Prod 2005, 68(3):349-353.
74. 2+). J Hazard Mater 2005, 122(1):7-15.
75. Lopes M.S., de Souza Pietra R.C., Borgati T.F., Romeiro C.F., Júnior P.A., Romanha A.J., et al. Synthesis and evaluation of the anti parasitic activity of aromatic nitro compounds. Eur J Med Chem 2011, 46(11):5443-5447.
76. López J.M.S., Insua M.M., Baz J.P., Puentes J.L.F., Hernández L.M.C. New cytotoxic indolic metabolites from a marine Streptomyces. J Nat Prod 2003, 66(6):863-864.
77. Lu J., Ma Y., Liang J., Xing Y., Xi T., Lu Y. Aureolic acids from a marine-derived Streptomyces sp. WBF16. Microbiol Res 2012, 167:590-595.
78. Macherla V.R., Liu J., Bellows C., Teisan S., Nicholson B., Lam K.S., et al. Glaciapyrroles A, B, and C, pyrrolosesquiterpenes from a Streptomyces sp. isolated from an Alaskan marine sediment. J Nat Prod 2005, 68(5):780-783.
79. Manam R.R., Teisan S., White D.J., Nishino T., Grodberg J., Neuteboom S.T.C., et al. Lajollamycin, a nitro-tetraene spiro-b-lactone-g-lactam antibiotic from the marine actinomycete Streptomyces nodosus. J Nat Prod 2005, 68:240-243.
80. Manivasagan P., Venkatesan J., Sivakumar K., Kim S.-K. Marine actinobacterial metabolites: current status and future perspectives. Microbiol Res 2013, 168:311-332.
81. Mann J. Natural products as immunosuppressive agents. Nat Prod Rep 2001, 18(4):417-430.
82. Mao Y., Varoglu M., Sherman D.H. Molecular characterization and analysis of the biosynthetic gene cluster for the antitumor antibiotic mitomycin C from Streptomyces lavendulae NRRL 2564. Chem Biol 1999, 6(4):251-263.
83. Maskey R.P., Helmke E., Laatsch H. Himalomycin A and B: isolation and structure elucidation of new fridamycin type antibiotics from a marine Streptomyces isolate. J Antibiot 2003, 56(11):942-949.
84. Maskey R.P., Li F., Qin S., Fiebig H.H., Laatsch H. Chandrananimycins A approximately C: production of novel anticancer antibiotics from a marine Actinomadura sp. isolate M048 by variation of medium composition and growth conditions. J Antibiot 2003, 56(7):622-634.
85. Maskey R.P., Sevvana M., Usón I., Helmke E., Laatsch H. Gutingimycin: a highly complex metabolite from a marine streptomycete. Angew Chem Int Ed 2004, 43(10):1281-1283.
86. Maskey R.P., Helmke E., Kayser O., Fiebig H.H., Maier A., Busche A., et al. Anti-cancer and antibacterial trioxacarcins with high anti-malaria activity from a marine Streptomycete and their absolute stereochemistry. J Antibiot 2004, 57(12):771-779.
87. Mayer A., Rodríguez A.D., Berlinck R.G., Hamann M.T. Marine pharmacology in 2003-4: marine compounds with anthelmintic antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action. Comp Biochem Physiol Part C: Toxicol Pharmacol 2007, 145(4):553-581.
88. McArthur K.A., Mitchell S.S., Tsueng G., Rheingold A., White D.J., Grodberg J., et al. Lynamicins A-E, chlorinated bisindole pyrrole antibiotics from a novel marine actinomycete. J Nat Prod 2008, 71(10):1732-1737.
89. Melisi D., Chiao P.J. NF-κB as a target for cancer therapy. Expert Opin Therap Targets 2007, 11(2):133-144.
90. Mikami Y. Biological work on medically important Nocardia species. Actinomycetologica 2007, 21(1):46-51.
91. Miller E.D., Kauffman C.A., Jensen P.R., Fenical W. Piperazimycins: cytotoxic hexadepsipeptides from a marine-derived bacterium of the genus Streptomyces. J Org Chem 2007, 72(2):323-330.
92. Mincer T.J., Fenical W., Jensen P.R. Culture-dependent and culture-independent diversity within the obligate marine actinomycete genus Salinispora. Appl Environ Microbiol 2005, 71(11):7019-7028.
93. Mitchell S.S., Nicholson B., Teisan S., Lam K.S., Barbara C. Aureoverticillactam, a novel 22-atom macrocyclic lactam from the marine actinomycete Streptomyces aureoverticillatus. J Nat Prod 2004, 67(8):1400-1402.
94. Moore B.S., Trischman J.A., Seng D., Kho D., Jensen P.R., Fenical W. Salinamides, antiinflammatory depsipeptides from a marine streptomycete. J Org Chem 1999, 64(4):1145-1150.
95. Morens D.M., Folkers G.K., Fauci A.S. The challenge of emerging and re-emerging infectious diseases. Nature 2004, 430(6996):242-249.
96. Morgenbesser S.D., Williams B.O., Jacks T., DePinho R.A. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 1994, 371:72-74.
97. Oh D.-C., Gontang E.A., Kauffman C.A., Jensen P.R., Fenical W. Salinipyrones and pacificanones, mixed-precursor polyketides from the marine actinomycete Salinispora pacifica. J Nat Prod 2008, 71(4):570-575.
98. Okami Y., Hotta K. Search and discovery of new antibiotics. Good fellow. Actinomycetes in biotechnology 1988, 33-67. Academic Press Inc., New york. M. Williams, S.T.M. Mordarski (Eds.).
99. Olano C., Méndez C., Salas J.A. Antitumor compounds from marine actinomycetes. Mar Drugs 2009, 7(2):210-248.
100. Oldfield C., Wood N.T., Gilbert S.C., Murray F.D., Faure F.R. Desulphurisation of benzothiophene and dibenzothiophene by actinomycete organisms belonging to the genus Rhodococcus, and related taxa. Antonie Van Leeuwenhoek 1998, 74(1):119-132.
101. Pathirana C., Jensen P.R., Fenical W. Marinone and debromomarinone: antibiotic sesquiterpenoid naphthoquinones of a new structure class from a marine bacterium. Tetrahedron Lett 1992, 33(50):7663-7666.
102. Pathom-Aree W., Stach J.E.M., Ward A.C., Horikoshi K., Bull A.T., Goodfellow M. Diversity of actinomycetes isolated from Challenger Deep sediment (10, 898m) from the Mariana Trench. Extremophiles 2006, 10:181-189.
103. Pathom-Aree W., Nogi Y., Ward A.C., Horikoshi K., Bull A.T., Goodfellow M. Dermacoccus barathri sp. nov. and Dermacoccus profundi sp. nov., novel actinomycetes isolated from deep-sea mud of the Mariana Trench. Int J Syst Evol Microbiol 2006, 56(10):2303-2307.
104. Payne D.J., Gwynn M.N., Holmes D.J., Pompliano D.L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discovery 2006, 6(1):29-40.
105. Peláez F. The historical delivery of antibiotics from microbial natural products-can history repeat?. Biochem Pharmacol 2006, 71(7):981-990.
106. Peschke U., Schmidt H., Zhang H.Z., Piepersberg W. Molecular characterization of the lincomycin-production gene cluster of Streptomyces lincolnensis 78-11. Mol Microbiol 2006, 16(6):1137-1156.
107. Pimentel-Elardo S.M., Kozytska S., Bugni T.S., Ireland C.M., Moll H., Hentschel U. Anti-parasitic compounds from Streptomyces sp. strains isolated from Mediterranean sponges. Mar Drugs 2010, 8(2):373-380.
108. Pinner R.W., Teutsch S.M., Simonsen L., Klug L.A., Graber J.M., Clarke M.J., et al. Trends in infectious diseases mortality in the United States. J Am Med Assoc 1996, 275(3):189-193.
109. Prudhomme J., McDaniel E., Ponts N., Bertani S., Fenical W., Jensen P., et al. Marine actinomycetes: a new source of compounds against the human malaria parasite. PLoS ONE 2008, 3(6):e2335.
110. Rabea E.I., Badawy M.E.-T., Stevens C.V., Smagghe G., Steurbaut W. Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules 2003, 4(6):1457-1465.
111. Rath J.-P., Kinast S., Maier M.E. Synthesis of the fully functionalized core structure of the antibiotic abyssomicin C. Org Lett 2005, 7(14):3089-3092.
112. Ravikumar S., Fredimoses M., Gnanadesigan M. Anticancer property of sediment actinomycetes against MCF-7 and MDA-MB-231 cell lines. Asian Pacific J Tropical Biomed 2012, 2(2):92-96.
113. Ravikumar S., Gnanadesigan M., Thajuddin N., Chakkaravarthi V., Banerjee B. Anticancer property of sponge associated actinomycetes along Palk Strait. J Pharm Res 2010, 3(10):2415-2417.
114. Ravikumar S., Thajuddin N., Suganthi P., Jacob Inbaneson S., Vinodkumar T. Bioactive potential of seagrass bacteria against human bacterial pathogens. J Environ Biol 2010, 31(3):387-389.
115. Ravikumar S., Gnanadesigan M., Saravanan A., Monisha N., Brindha V., Muthumari S. Antagonistic properties of seagrass associated Streptomyces sp., RAUACT-1: a source for anthraquinone rich compound. Asian Pacific J Tropical Med 2012, 5(11):887-890.
116. Renner M.K., Shen Y.-C., Cheng X.-C., Jensen P.R., Frankmoelle W., Kauffman C.A., et al. new antiinflammatory cyclic peptides produced by a marine bacterium (Streptomyces sp.). J Am Chem Soc 1999, 121(49):11273-11276.
117. Reynolds J.M., El Bissati K., Brandenburg J., Günzl A., Mamoun C.B. Antimalarial activity of the anticancer and proteasome inhibitor bortezomib and its analog ZL3B. BMC Clin Pharmacol 2007, 7(1):7-13.
118. Reynolds L., Killilea S., Redmer D. Angiogenesis in the female reproductive system. FASEB J 1992, 6(3):886-892.
119. Riedlinger J., Reicke A., Zähner H., Krismer B., Bull A.T., Maldonado L.A., et al. Abyssomicins, inhibitors of the para-aminobenzoic acid pathway produced by the marine Verrucosispora strain AB-18-032. J Antibiot 2004, 57(4):271-279.
120. Risau W. Mechanisms of angiogenesis. Nature 1997, 386(6626):671-674.
121. Rodriguez J.C., Fernandez P.I.L., Perez B.J., Canedo L.M. IB-00208, a new cytotoxic polycyclic xanthone produced by a marine-derived Actinomadura II. Isolation, physico-chemical properties and structure determination. J Antibiot 2003, 56(3):318-321.
122. Salomon C.E., Magarvey N.A., Sherman D.H. Merging the potential of microbial genetics with biological and chemical diversity: an even brighter future for marine natural product drug discovery. Nat Prod Rep 2004, 21(1):105-121.
123. Sato S., Iwata F., Yamada S., Kawahara H., Katayama M. Usabamycins A-C: new anthramycin-type analogues from a marine-derived actinomycete. Bioorg Med Chem Lett 2011, 21(23):7099-7101.
124. Sattler I., Thiericke R., Zeeck A. The manumycin-group metabolites. Nat Prod Rep 1998, 15(3):221-240.
125. Schneider K., Nachtigall J., Hanchen A., Nicholson G., Goodfellow M., Sussmuth R.D., et al. Lipocarbazoles, secondary metabolites from Tsukamurella pseudospumae Acta 1857 with antioxidative activity. J Nat Prod 2009, 72(10):1768-1772.
126. Schneider K., Keller S., Wolter F.E., Röglin L., Beil W., Seitz O., et al. Proximicins A, B, and C-antitumor furan analogues of netropsin from the marine actinomycete Verrucosispora induce upregulation of p53 and the cyclin kinase inhibitor p21. Angew Chem Int Ed 2008, 47(17):3258-3261.
127. Schultz A.W., Oh D.-C., Carney J.R., Williamson R.T., Udwary D.W., Jensen P.R., et al. Biosynthesis and structures of cyclomarins and cyclomarazines, prenylated cyclic peptides of marine actinobacterial origin. J Am Chem Soc 2008, 130(13):4507-4516.
128. Schumacher R.W., Talmage S.C., Miller S.A., Sarris K.E., Davidson B.S., Goldberg A. Isolation and structure determination of an antimicrobial ester from a marine sediment-derived bacterium. J Nat Prod 2003, 66(9):1291-1293.
129. Shi C., Zhu Y., Ran X., Wang M., Su Y., Cheng T. Therapeutic potential of chitosan and its derivatives in regenerative medicine. J Surg Res 2006, 133(2):185-192.
130. Shin H.J., Kim T.S., Lee H.-S., Park J.Y., Choi I.-K., Kwon H.J. Streptopyrrolidine, an angiogenesis inhibitor from a marine-derived Streptomyces sp. KORDI-3973. Phytochemistry 2008, 69(12):2363-2366.
131. Shin H.J., Mondol M., Yu T.K., Lee H.-S., Lee Y.-J., Jung H.J., et al. An angiogenesis inhibitor isolated from a marine-derived actinomycete, Nocardiopsis sp. 03N67. Phytochem Lett 2010, 3(4):194-197.
132. Shukla A.K., Singh B.K., Patra S., Dubey V.K. Rational approaches for drug designing against leishmaniasis. Appl Biochem Biotechnol 2010, 160(8):2208-2218.
133. Smith W.C., Xiang L., Shen B. Genetic localization and molecular characterization of the nonS gene required for macrotetrolide biosynthesis in Streptomyces griseus DSM40695. Antimicrob Agents Chemother 2000, 44(7):1809-1817.
134. Socha A.M., LaPlante K.L., Rowley D.C. New bisanthraquinone antibiotics and semi-synthetic derivatives with potent activity against clinical Staphylococcus aureus and Enterococcus faecium isolates. Bioorg Med Chem 2006, 14(24):8446-8454.
135. Soria-Mercado I.E., Prieto-Davo A., Jensen P.R., Fenical W. Antibiotic terpenoid chloro-dihydroquinones from a new marine actinomycete. J Nat Prod 2005, 68(6):904-910.
136. Stach J.E.M., Maldonado L.A., Ward A.C., Goodfellow M., Bull A.T. New primers for the class Actinobacteria: application to marine and terrestrial environments. Environ Microbiol 2003, 5(10):828-841.
137. Stritzke K., Schulz S., Laatsch H., Helmke E., Beil W. Novel caprolactones from a marine streptomycete. J Nat Prod 2004, 67(3):395-401.
138. Talbot G.H., Bradley J., Edwards J.E., Gilbert D., Scheld M., Bartlett J.G. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 2006, 42(5):657-668.
139. Tringe S.G., Von Mering C., Kobayashi A., Salamov A.A., Chen K., Chang H.W., et al. Comparative metagenomics of microbial communities. Sci 2005, 308(5721):554-557.
140. Urbina J.A., Docampo R. Specific chemotherapy of Chagas disease: controversies and advances. Trends Parasitol 2003, 19(11):495-501.
141. Wanner L.A. A patchwork of Streptomyces species isolated from potato common scab lesions in North America. Am J Potato Res 2009, 86(4):247-264.
142. Ward A.C., Bora N. Diversity and biogeography of marine actinobacteria. Curr Opin Microbiol 2006, 9(3):279-286.
143. Watve M.G., Tickoo R., Jog M.M., Bhole B.D. How many antibiotics are produced by the genus Streptomyces?. Arch Microbiol 2001, 176(5):386-390.
144. Weidner N., Carroll P., Flax J., Blumenfeld W., Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993, 143(2):401-409.
145. Weyland H. Actinomycetes in North Sea and Atlantic Ocean sediments. Nature 1969, 223:858.
146. Williams P.G. Panning for chemical gold: marine bacteria as a source of new therapeutics. Trends Biotechnol 2009, 27(1):45-52.
147. Williams P.G., Miller E.D., Asolkar R.N., Jensen P.R., Fenical W., Arenicolides A.C. 26-membered ring macrolides from the marine actinomycete Salinispora arenicola. J Org Chem 2007, 72(14):5025-5034.
148. Williams P.G., Buchanan G.O., Feling R.H., Kauffman C.A., Jensen P.R., Fenical W. New cytotoxic salinosporamides from the marine actinomycete Salinispora tropica. J Org Chem 2005, 70(16):6196-6203.
149. Woolhouse M.E. Epidemiology: emerging diseases go global. Nature 2008, 451(7181):898-899.
150. Wu S.J., Fotso S., Li F., Qin S., Laatsch H. Amorphane sesquiterpenes from a marine Streptomyces sp. J Nat Prod 2007, 70(2):304-306.
151. Wu S.J., Fotso S., Li F., Qin S., Kelter T., Fiebig H.H., et al. 39-N-carboxamidostaurosporine and selina-4(14),7(11)-diene-8,9-diol, new metabolites from a marine Streptomyces sp. J Antibiot 2006, 59:331-337.
152. Wu Z., Xie L., Xia G., Zhang J., Nie Y., Hu J., et al. A new tetrodotoxin-producing actinomycete, Nocardiopsis dassonvillei, isolated from the ovaries of puffer fish Fugu rubripes. Toxicon 2005, 45(7):851-859.
153. Yan J., Li X., Liu L., Wang F., Zhu T.W., Zhang Q. Potential use of collagen-chitosan-hyaluronan tri-copolymer scaffold for cartilage tissue engineering. Artif Cells Blood Substitutes Biotechnol 2006, 34(1):27-39.